MicroRNA expression in pre-treatment plasma of patients with benign breast diseases and breast cancer

Oncotarget
Mirelle LagendijkJohn W M Martens

Abstract

MicroRNAs (miRs) are small RNA molecules, influencing messenger RNA (mRNA) expression and translation, and are readily detectable in blood. Some have been reported as potential breast cancer biomarkers. This study aimed to identify and validate miRs indicative of breast cancer. Based on the discovery and literature, 18 potentially informative miRs were quantified in the validation cohort. Irrespective of patient and tumour characteristics, hsa-miR-652-5p was significantly upregulated in the malignant compared to benign patients (1.26 fold, P = 0.005) and therefore validated as potential biomarker. In the validation cohort literature-based hsa-let-7b levels were higher in malignant patients as well (1.53 fold, P = 0.011). Two miRs differentiated benign wildtype from benign BRCA1 mutation carriers and an additional 8 miRs differentiated metastastic (n = 8) from non-metastatic (n = 41) cases in the validation cohort. Pre-treatment plasma samples were collected of patients with benign breast disease and breast cancer and divided over a discovery (n = 31) and validation (n = 84) cohort. From the discovery cohort miRs differentially expressed between benign and malignant cases were identified using a 2,000-miR microarray. Literature-...Continue Reading

References

Jul 1, 1990·Statistics in Medicine·Y Hochberg, Y Benjamini
Jun 27, 2003·Breast Cancer Research and Treatment·Wenchi LiangMarc E Lippman
Aug 17, 2005·Cancer Research·Marilena V IorioCarlo M Croce
Jan 19, 2007·The New England Journal of Medicine·Norman F BoydMartin J Yaffe
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·John A FoekensJohn W M Martens
Nov 22, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Marilena V IorioCarlo M Croce
May 21, 2009·BMC Research Notes·Weizhu ZhuEdward R Sauter
Apr 6, 2011·Expert Review of Molecular Diagnostics·Bianca MostertStefan Sleijfer
Apr 21, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Anieta M SieuwertsJohn W M Martens
Sep 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dharanija MadhavanBarbara Burwinkel
Oct 6, 2012·Methods : a Companion to Methods in Enzymology·Thorarinn BlondalIna K Dahlsveen
Oct 12, 2012·Journal of Cancer Research and Clinical Oncology·Haiyan SiChengjin Hu
Jun 26, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maurice ChanAnn Siew-Gek Lee
Nov 7, 2013·PloS One·Katarina CukBarbara Burwinkel
Jun 20, 2014·Molecular and Cellular Biochemistry·Elif ErturkIsmet Tasdelen
Dec 31, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kristine Kleivi SahlbergLibero Santarpia
Mar 15, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Yingjie ShaoJingting Jiang
Oct 8, 2015·BMJ : British Medical Journal·Sepideh SaadatmandMadeleine M A Tilanus-Linthorst
Oct 16, 2015·Technology in Cancer Research & Treatment·Leping LiChangqing Jing
Jan 7, 2016·Oncotarget·Pierre FrèresGuy Jerusalem
Jan 11, 2016·Cancer Science·Akihiko ShimomuraTakahiro Ochiya

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
chips

Software Mentioned

NormFinder
GeNorm
MultiD
GenEx

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

© 2022 Meta ULC. All rights reserved